Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_assertion type Assertion NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_head.
- NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_provenance.
- NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_assertion evidence source_evidence_literature NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_provenance.
- NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_assertion SIO_000772 23660859 NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_provenance.
- NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_assertion wasDerivedFrom befree-20140225 NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_provenance.
- NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_assertion wasGeneratedBy ECO_0000203 NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_provenance.